Local Institution - 0257

Porto Alegre, Rio Grande do Sul 90035-903

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma — Stopped early